Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT05756244
Recruiting Observational

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

NCT05756244 · tracked via the Priya Life Science France tracker
Sponsor
University of Calgary
Phase
Observational
Started
2023-04-04
Last updated
2025-11-28

Condition(s) studied

Pregnancy RelatedVenous Thromboembolism

Study summary

The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * 18 years of age or older * Requires anticoagulation during the antepartum period of pregnancy for a VTE indication, including at least one of: 1. Objectively confirmed VTE (DVT, superficial vein thrombosis \[SVT\], PE or unusual site thrombosis) diagnosed during the current pregnancy; 2. Objectively confirmed VTE diagnosed in a prior pregnancy; 3. Objectively confirmed VTE diagnosed when not pregnant; 4. Inherited or acquired thrombophilia requiring anticoagulation. * Receiving any dose or type of LMWH during the antepartum period Exclusion Criteria: * Anticoagulation for a non-VTE indication, including prosthetic heart valves, atrial fibrillation, prevention of placenta-mediated pregnancy complications, or prevention of recurrent pregnancy loss (participants can be included with a diagnosis of antiphospholipid syndrome (APS) with or without thrombotic events) * Unable to provide or declined consent. * Home or birthing centre planned delivery.

Primary outcome measure(s)

Trial sites (14)

FacilityCityRegionStatus
Duke University Hospital Durham North Carolina Recruiting
Foothills Medical Centre Calgary Alberta Recruiting
Royal Alexandra Hospital Edmonton Alberta Recruiting
BC Women's Hospital and Health Centre Vancouver British Columbia Recruiting
St. Boniface Hospital Winnipeg Manitoba Recruiting
McMaster University Medical Centre Hamilton Ontario Recruiting
The Ottawa Hospital - General Campus Ottawa Ontario Recruiting
Montfort Hospital Ottawa Ontario Recruiting
Mount Sinai Hospital Toronto Ontario Recruiting
CHU Sainte-Justine Montreal Quebec Recruiting
The Sir Mortimer B. Davis Jewish General Hospital Montreal Quebec Recruiting
Aarhus University Hospital Aarhus Denmark Recruiting
Le Centre Hospitalier Universitaire of Saint-Etienne Saint-Etienne France Recruiting
Hopitaux universitaires de Geneve Geneva Switzerland Recruiting

More University of Calgary trials in France

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Recruiting
Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms Recruiting

Other trials for the same condition

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing Recruiting
Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg) Starting soon
Statins for Venous Event Reduction in Patients With Venous Thromboembolism Recruiting
Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER ) Recruiting
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05756244 on ClinicalTrials.gov ↗ ← All trials in France